As a result, the expression levels of key regulatory factors involved in mitochondrial metabolism and organelle biogenesis, namely, PGC-1α, TFAM, and NRF-2, have been reported to be reduced in NAFLD [43,44,45]. Here, TFAM is linked to metabolic dysfunction-associated steatotic liver disease.